The ABCs of cardiovascular disease prevention: communicating what we know in 2026.

Lea R Goren, Allison W Peng, Alexander C Razavi, Michael J Blaha, Roger S Blumenthal, Aaron L Troy

Abstract readReview

In one paragraph

Review in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lea R GorenCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Allison W PengCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Alexander C RazaviCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Michael J BlahaCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Roger S BlumenthalCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Aaron L TroyCiccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite numerous breakthroughs in Preventive Cardiology, control of key cardiovascular disease (CVD) risk factors including blood pressure and diabetes has stagnated in the past decade, driven in part by the obesity epidemic and population aging. Improving dissemination and implementation of the latest guidelines and evidence-based recommendations is a key national priority for CVD prevention. The ABCs of CVD Prevention is a structured framework identifying actionable domains for CVD prevention, first published in 2001 and last updated in 2021, designed to maximize clarity and uptake of key preventive recommendations. In this State-of-the-Art review, we provide a comprehensively updated version of the ABCs reflecting what we know in 2026, with two practice pearls per domain and accompanying figures and materials to support dissemination. The ABCs of CVD Prevention are:

Indexed as

Cardiovascular diseaseCardiovascular disease preventionImplementation scienceRisk assessmentRisk enhancers

Identifiers

PMID42404752

DOI10.1016/j.ajpc.2026.101570

PMCPMC13328869

What Socratic holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.